MANHATTAN PHARMACEUTICALS INC — Form D/A
MANHATTAN PHARMACEUTICALS INC of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2012-02-29. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-02-29
- Form: D/A
- Accession: 0001144204-12-011931
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $25.0M
- Amount sold: $25.0M
- Minimum investment: $50K
- Investors: 416
- Date of first sale: 2011-12-30
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-53361
Issuer
- Name: MANHATTAN PHARMACEUTICALS INC
- CIK: 0001001316
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 787 SEVENTH AVENUE, 48TH FLOOR, NEW YORK, NY, 10019
- Phone: 212-554-4305
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Michael Weiss | Director | Richmond, VA |
| Michael Weiss | Executive Officer | Richmond, VA |
| SEAN POWER | Executive Officer | DORCHESTER, MA |
| Neil Herskowitz | Director | Scottsdale, AZ |
| Timothy McInerney | Director | New York, NY |
| Douglas Abel | Director | NEW YORK, NY |
| Michael McGuinness | Executive Officer | NEW YORK, NY |
| Richard Steinhart | Director | NEW YORK, NY |
Other filings by this issuer (3)
More